Itzhh Capsule contains Itraconazole 100mg, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Itzhh Capsule is indicated for the management of infections such as aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and other systemic and superficial mycoses caused by susceptible fungi. The medication is administered orally and is well absorbed, with bioavailability enhanced when taken with food. It is metabolized primarily by the liver via the cytochrome P450 system, necessitating caution in patients with hepatic impairment and potential drug interactions. Common adverse effects include gastrointestinal disturbances, headache, dizziness, and rash, while serious side effects may involve hepatotoxicity and cardiac issues such as congestive heart failure. Itzhh Capsule should be used under medical supervision, with appropriate monitoring of liver function and consideration of contraindications, including pregnancy and concomitant use of certain medications. Proper adherence to prescribed dosage and duration is essential to ensure therapeutic efficacy and reduce the risk of resistance or relapse.